close 73% van de retail rekeningen verliezen gelden met de handel in CFD`s bij deze aanbieder. Investeringen zijn risicovol en zijn niet geschikt voor alle beleggers. CFD`s zijn complexe instrumenten met een hoog risico om snel gelden te verliezen vanwege het hefboomeffect. 73% van de retail beleggers lijdt verlies bij het handelen in CFD`s met deze aanbieder. Het is belangrijk dat u goed begrijpt hoe CFD`s werken en dat u nagaat of u zich het hoge risico op verlies kunt permitteren.
ZoekenZoeken
Change languageNederlands
Dashboard

MDT

101.33

+0.34%↑

A

136.53

+1.22%↑

VEEV

223.66

+0.86%↑

HQY

84.98

+1%↑

NEOG

9.86

+0.51%↑

MDT

101.33

+0.34%↑

A

136.53

+1.22%↑

VEEV

223.66

+0.86%↑

HQY

84.98

+1%↑

NEOG

9.86

+0.51%↑

MDT

101.33

+0.34%↑

A

136.53

+1.22%↑

VEEV

223.66

+0.86%↑

HQY

84.98

+1%↑

NEOG

9.86

+0.51%↑

MDT

101.33

+0.34%↑

A

136.53

+1.22%↑

VEEV

223.66

+0.86%↑

HQY

84.98

+1%↑

NEOG

9.86

+0.51%↑

MDT

101.33

+0.34%↑

A

136.53

+1.22%↑

VEEV

223.66

+0.86%↑

HQY

84.98

+1%↑

NEOG

9.86

+0.51%↑

Home・Aandelen Lijst・VIRIDIAN THERAPEUTICS INC
Search

VIRIDIAN THERAPEUTICS INC

Open

SectorGezondheidszorg

33.02 0.61

Strong Buy

Prijsupdate 26 jan 2026, 19:45 UTC

BuySell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

32.38

Max

33.32

Belangrijke statistieken

By Trading Economics

Inkomsten

66M

-35M

Verkoop

70M

71M

Winstmarge

-49.028

Werknemers

143

EBITDA

66M

-34M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+35.14% upside

Dividenden

By Dow Jones

Volgende Winsten

25 feb 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1B

3.2B

Vorige openingsprijs

32.41

Vorige sluitingsprijs

33.02

Nieuwssentiment

By Acuity

33%

67%

70 / 352 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Very Strong Bearish Evidence

12 / 13.14 Steun & Weerstand

VIRIDIAN THERAPEUTICS INC Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 jan 2026, 23:49 UTC

Marktinformatie

Oil Falls on Possible Technical Correction -- Market Talk

DJ

Lezen

25 jan 2026, 23:43 UTC

Marktinformatie

Correction to Gold Rises Above $5000/oz Market Talk

DJ

Lezen

25 jan 2026, 23:43 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

DJ

Lezen

25 jan 2026, 23:43 UTC

Marktinformatie

Nikkei May Fall After Yen's Sharp Rebound -- Market Talk

DJ

Lezen

25 jan 2026, 23:36 UTC

Marktinformatie

Gold Rises Above $5,000/oz for First Time Amid Geopolitical Tensions -- Market Talk

DJ

Lezen

25 jan 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Merck No Longer in Talks to Acquire Revolution Medicines, Sources Say -- WSJ

DJ

Lezen

25 jan 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Companies Had Been Discussing Roughly $30B Deal -- WSJ

DJ

Lezen

25 jan 2026, 19:30 UTC

Acquisities, Fusies, Overnames

Merck No Longer in Talks to Buy Revolution Medicines -- WSJ

DJ

Lezen

24 jan 2026, 09:20 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

24 jan 2026, 09:20 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

24 jan 2026, 09:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

24 jan 2026, 09:20 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

DJ

Lezen

24 jan 2026, 06:18 UTC

Acquisities, Fusies, Overnames

Our Boston Scientific Pick Has Stumbled. Acquiring Penumbra Will Help the Stock. -- Barrons.com

DJ

Lezen

23 jan 2026, 22:30 UTC

Marktinformatie

Global Equities Roundup: Market Talk

DJ

Lezen

23 jan 2026, 22:30 UTC

Marktinformatie

Trump Seen Using Canada's EV Deal With China to Extract Concessions -- Market Talk

DJ

Lezen

23 jan 2026, 22:03 UTC

Winsten

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

DJ

Lezen

23 jan 2026, 21:52 UTC

Winsten
Acquisities, Fusies, Overnames

GE Aerospace's Earnings Worried the Market. What CEO Larry Culp Says. -- Barrons.com

DJ

Lezen

23 jan 2026, 21:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

DJ

Lezen

23 jan 2026, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

DJ

Lezen

23 jan 2026, 21:50 UTC

Marktinformatie

Financial Services Roundup: Market Talk

DJ

Lezen

23 jan 2026, 21:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

DJ

Lezen

23 jan 2026, 21:39 UTC

Winsten

Intel Returns to Losses as Supply Shortages, Spending Weigh on Q4 Results and Forecast -- 5th Update

DJ

Lezen

23 jan 2026, 21:15 UTC

Acquisities, Fusies, Overnames

Eaton Completes Acquisition Of Ultra PCS Limited, Expanding Capabilities And Solutions For Next-generation Aerospace And Defense Markets >ETN

DJ

Lezen

23 jan 2026, 21:12 UTC

Winsten

CSX Stock Rises After Earnings Miss Estimates. It's the Outlook. -- Barrons.com

DJ

Lezen

23 jan 2026, 20:31 UTC

Winsten

These Stocks Are Today's Movers: Intel, AMD, Capital One, Booz Allen, BitGo, Fortinet, and More -- Barrons.com

DJ

Lezen

23 jan 2026, 20:12 UTC

Marktinformatie

Oil Futures Rebound on Iran, Russia-Ukraine Risk -- Market Talk

DJ

Lezen

23 jan 2026, 20:07 UTC

Marktinformatie

U.S. Natural Gas Posts Record Weekly Gain on Winter Storm -- Market Talk

DJ

Lezen

23 jan 2026, 19:36 UTC

Marktinformatie

Dollar Weakens Against Yen Amid Intervention Chatter -- Market Talk

DJ

Lezen

23 jan 2026, 19:30 UTC

Marktinformatie
Winsten

Intel's Stock Has Limited Catalysts Ahead, Analysts Say -- Market Talk

DJ

Lezen

23 jan 2026, 19:18 UTC

Marktinformatie

Gold and Silver Step Up to More Records -- Market Talk

DJ

Lezen

Peer Vergelijking

Prijswijziging

VIRIDIAN THERAPEUTICS INC Prognose

Koersdoel

By TipRanks

35.14% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 44.5 USD  35.14%

Hoogste 61 USD

Laagste 34 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor VIRIDIAN THERAPEUTICS INC - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

13

Buy

0

Hold

0

Sell

Gebaseerd op 13 analisten die aandelenratings hebben gegeven aan VIRIDIAN THERAPEUTICS INC - Dist in de afgelopen 3 maanden.

Technische score

By Trading Central

12 / 13.14Steun & Weerstand

Korte Termijn

Very Strong Bearish Evidence

Recent bearish events outweigh bullish events.

Gemiddeld Termijn

Bearish Evidence

All events are bearish.

Lange Termijn

Strong Bearish Evidence

All events are bearish.

Sentiment

By Acuity

70 / 352 Rangschikking in Gezondheidszorg

Nieuwssentiment

Bullish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Andere aandelen uit de sector

MDT

Medtronic PLC

101.33

↑ +0.34%

A

Agilent Technologies Inc

136.53

↑ +1.22%

VEEV

Veeva Systems Inc

223.66

↑ +0.86%

HQY

HealthEquity Inc

84.98

↑ +1%

NEOG

Neogen Corp

9.86

↑ +0.51%
help-icon Live chat